Association between Albuminuria and Different Body Constitution in Type 2 Diabetes Patients: Taichung Diabetic Body Constitution Study

Abstract

Objective. Albuminuria in type 2 diabetes mellitus (T2DM) patients increases the risk of diabetic nephropathy, the leading cause of end-stage renal disease worldwide. Because albuminuria is modifiable, identifying relevant risk factors could facilitate prevention and/or management. This cross-sectional study investigated whether body constitution (BC) independently predicts albuminuria. Method. Patients with T2DM (n=846) received urinalysis, a blood test, and diabetic retinopathy examination. Albuminuria was defined by an elevated urinary albumin/creatinine ratio (≥30 μg/mg). BC type (Yang deficiency, Yin deficiency, and Phlegm stasis) was assessed using a body constitution questionnaire (BCQ). Traditional risk factors for albuminuria were also recorded. Odds ratios (ORs) of albuminuria for BC were estimated using multivariate logistic regression. Results. Albuminuria was more prevalent in patients with Yang deficiency or Phlegm stasis (both P<0.01). After adjustment, patients with both Yang deficiency and Phlegm stasis exhibited a significantly higher risk of albuminuria (OR = 3.037; 95% confidence interval = 1.572-5.867, and P<0.001). Conclusion. BC is strongly associated with albuminuria in T2DM patients. Using a BCQ to assess BC is noninvasive, convenient, and inexpensive and can provide information for health care professionals to identify T2DM patients who are at a high risk of albuminuria.

[ProQuest: [...] denotes non US-ASCII text; see PDF]

Cheng-Hung Lee 1, 2, 3 and Tsai-Chung Li 4,5 and Chia-I Tsai 6 and Shih-Yi Lin 7 and I-Te Lee 7,8,9 and Hsin-Jung Lee 10 and Ya-Chi Wu 10 and Yi-Chang Su 1, 3

Academic Editor:Cheryl Hawk

1, Graduate Institute of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan
2, Department of Traditional Chinese Medicine, Han Ming Hospital, Changhua 50072, Taiwan
3, School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan
4, Graduate Institute of Biostatistics, China Medical University, Taichung 40402, Taiwan
5, Department of Health Administration, College of Health Science, Asian University, Taichung 41354, Taiwan
6, Department of Traditional Chinese Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan
7, Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan
8, Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
9, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan
10, Division of New Drugs, Center for Drug Evaluation, Taipei 11557, Taiwan

Received 3 July 2015; Accepted 4 October 2015; 26 October 2015

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Introduction

Global prevalence of diabetes, a chronic metabolic disease, has increased rapidly and is estimated to reach over 552 million by 2030 [1]. Diabetic nephropathy, a severe vascular complication of diabetes, is the leading cause of end-stage renal disease (ESRD) in many countries [2, 3]. ESRD considerably influences public health and health care economy [4-6]. According to the annual report of the United States Renal Data System (USRDS), Taiwan had the world's highest incidence and prevalence of ESRD during 2002-2005 and 2009, respectively [4, 7]. The Taiwan Society of Nephrology demonstrated that the increasing prevalence of diabetes was the main cause of the rising prevalence and incidence of ESRD in Taiwan [8]. Albuminuria is a modifiable and crucial risk factor for diabetic nephropathy [9, 10]. In addition, multinational and regional studies have revealed that Asian diabetic populations have a higher prevalence of albuminuria [11, 12]. Hence, reducing the risk of albuminuria is a key treatment goal for renal protection in patients with type 2 diabetes (T2DM) to prevent the progression of diabetic nephropathy.

Despite the vast efforts devoted to managing the potential risk factors for albuminuria, the global incidence of ESRD in patient with T2DM continues to rise [5, 8, 13]. This is probably because the pathogenesis of albuminuria is multifactorial, thus indicating an urgent necessity to discover other potential risk factors. Traditional Chinese medicine (TCM) may provide a novel insight into this problem. TCM, a type of frequently used complementary and alternative medicine (CAM) [14-16], emphasizes the concept of personalized medicine based on body constitution (BC) theory [17-19]. An individual's constitution status is formed by the state of Yang and Yin in his body. Yin and Yang deficiency BCs refer to the decrease of the material and energy level, respectively, and the imbalance between Yin and Yang may cause Phlegm stasis [17]. People with different BC types are variously prone to certain diseases and differ in disease progression [20, 21], and TCM practitioners treat patients with the same disease diagnosis differently according to each individual's body constitution, which is known as tong bing yi zhi in Chinese. Besides, to achieve optimal health promotion, TCM practitioners used to adopt individualized preventive methods based on BC [22-24].

Distinguishing T2DM patients who have a higher risk of albuminuria is essential for prevention or early treatment of diabetic nephropathy. In the current study, we sought to determine whether BC could be an independent predictor of albuminuria in 846 patients with T2DM recruited from a medical center with information of their BC status and data from urinalysis, blood test, and diabetic retinopathy (DR) examination.

2. Materials and Methods

2.1. Study Design and Participants

This cross-sectional study was conducted from February 2010 to February 2011 at the Diabetes Health Promotion Center of Taichung Veterans General Hospital in Taichung, Taiwan. The study protocol was approved by the Institutional Review Board of Taichung Veterans General Hospital (C10007). A total of 887 participants diagnosed with T2DM were referred by endocrinology and metabolism subspecialists from an outpatient clinic. Written informed consent was obtained from each participant. Every participant had to undergo the following tests for determining the risk factors for albuminuria: BC measurement, sociodemographic characteristics (including gender, age, body mass index, and waist circumference), lifestyle behaviors, diabetic history, lipid profile, blood pressure, kidney function, and DR. All the tests were performed on the same day. Forty-one participants who could not complete all laboratory tests were excluded. A total of 846 participants with T2DM were included in the final analysis. Figure 1 shows the recruitment flowchart of the study participants.

Figure 1: The flowchart of the study.

[figure omitted; refer to PDF]

If the sample size is fixed at 800 patients with type 2 diabetes, the power would be 0.8891, given that the association between BC and albuminuria (OR) was 2 with two-sided type 1 error of 5% and prevalence of 12.5% for BC. This is calculated with the use of a two-sided proportion test ( [figure omitted; refer to PDF] test) on the assumption that there is an albuminuria prevalence of 57.1% in patients with type 2 diabetes whose BC was Yang deficiency. This information came from our pilot study and Yang deficiency was the primary predictor of BC for albuminuria in study design stage.

2.2. Measurements

2.2.1. Body Constitution Measurement

All the participants were self-administered a body constitution questionnaire (BCQ) to evaluate their BC status. The items of the BCQ were generated from TCM textbooks and the published literature [17, 21, 25]. The initial items were translated into colloquial questions through a 2-stage Delphi process. The resulting questionnaire was tested to check for wording, sequencing, grammar, and ease of comprehension. Then, intraclass consistency was done to reduce the items of the questionnaire [17, 21, 25]. The BCQ demonstrates favorable factorial validity [21], and the Cronbach α of each constitution subscale in previous studies has been between 0.88 and 0.90 [21, 26, 27]. The BCQ comprised 44 items on a 5-point Likert-type scale from 1 (never happened ) to 5 (always happens ), including 19 items on Yang deficiency [17, 26], 16 items on Phlegm stasis [21], and 19 items on Yin deficiency [25, 27]. Some items belonging to these three scales overlapped, and the final score of each constitution was calculated by summing the scores of all items on each subscale. A higher score implied a greater deviation from the constitution. The score range of Yang deficiency is between 19 and 95, and the participant was diagnosed with Yang deficiency when the score reached over 30.5 [26]. For Phlegm stasis, the score range is 16 to 80, and the cut point for diagnosis is 26.5 [21]. As for Yin deficiency, the score range is 19 to 95, and the participant was diagnosed with Yin deficiency BC when the score is higher than 29.5 [27].

2.2.2. Detection of Albuminuria

Spot urine samples were collected from each participant and the urinary albumin concentrations were measured using immunoturbidimetry [28] at Taichung Veterans General Hospital. Daily urinary albumin secretion was estimated by calculating an elevated urinary albumin/creatinine ratio (ALB/Cr) [29-31]. Albuminuria was defined according to an elevated urinary albumin/creatinine ratio (≥30 μ g/mg) [30, 31].

2.2.3. Detection of Diabetic Retinopathy

Each participant received standardized central fundus photographic imaging and both eyes of each participant were photographed using a nonstereoscopic 45° digital nonmydriatic camera (CR-DGi, Canon, Inc., Tokyo, Japan). Experienced and trained endocrinology and metabolism subspecialists examined the fundus photographs in a masked manner. The DR severity of each eye was graded according to the International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales [32]. Participants who had at least one eye with either nonproliferative DR or proliferative DR were assigned to the DR group.

2.3. Data Collection

Traditional risk factors for albuminuria were derived to control for the confounding influence. The sociodemographic characteristics (gender, age, height, and waist circumference), lifestyle behaviors (smoking history, alcohol consumption, and exercise habits), diabetes history (diabetes duration, oral hypoglycemia agent, and insulin usage), and systolic and diastolic blood pressure of all the participants were investigated through personal interviews at the Diabetes Health Promotion Center of Taichung Veterans General Hospital. Fasting (>12 hours) blood samples were collected for measuring the level of fasting blood sugar, glycosylated hemoglobin (HbA1c), total cholesterol, total triglyceride, high-density lipoprotein, low-density lipoprotein (LDL), and creatinine (Cr). The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease four-variable equation: 186 × serum creatinine - 1.154 × age - 0.203 × 1.212 (if black) × 0.742 (if female) [33].

2.4. Statistical Analysis

Continuous and categorical variables were presented as mean ± standard deviation (SD) and number (%), respectively. For comparing the differences between groups, chi-square test and [figure omitted; refer to PDF] -test were used for categorical and continuous variables, respectively.

In the other published paper from Taichung Diabetic Body Constitution Study (TDBS), the independent effects of Yang deficiency, Phlegm stasis, and Yin deficiency on DR among T2DM patients had been explored [34]. In this study, we are interested in albuminuria, another diabetic microvascular complication. In addition to examining independent effects of BCs, we further examined their joint effect of different BCs on albuminuria.

We used hierarchical models for covariant variables to determine whether BC is an independent predictor of albuminuria. First, crude ORs were calculated without adjustment. Subsequently, sociodemographic characteristics, lifestyle behaviors, blood pressure, lipid profile, diabetes history, eGFR, and DR were sequentially entered into the model. Finally, the joint effect of Yang deficiency and Phlegm stasis on albuminuria was examined. A two-sided significance level was set at [figure omitted; refer to PDF] . All analyses were performed using SAS version (SAS Institute Inc., Cary, NC, USA).

3. Results

The study group comprised 366 (43%) females and 480 (57%) males with a mean age of 63.72 years (SD = 13.05 years), with a mean duration of diabetes of 8.92 years (SD = 7.92 years). Among the study participants, 232 (27.4%), 112 (13.2%), and 99 (11.7%) were diagnosed with Yin deficiency, Phlegm stasis, and Yang deficiency, respectively. Table 1 shows a comparison of sociodemographic characteristics, lifestyle behaviors, diabetic history, lipid profile, blood pressure, kidney function, and DR among the participants with and without Yang deficiency, Yin deficiency, and Phlegm stasis. Participants with Yin deficiency had a higher mean age. Patients with Yang deficiency, Phlegm stasis, and Yin deficiency had a higher proportion of females than those without corresponding BC. Patients with Phlegm stasis were less likely to have alcohol consumption and regular exercise habits. These patients had higher BMI and waist circumference. Higher percentage of insulin usage was noted in participants with Yang or Yin deficiency. Participants with Yin deficiency had lower eGFR level. Participants with Yang deficiency or Phlegm stasis were less likely to develop DR.

Table 1: Participants' characteristics.

	Yang deficiency ( [figure omitted; refer to PDF] )	Phlegm stasis ( [figure omitted; refer to PDF] )	Yin deficiency ( [figure omitted; refer to PDF] )
	Yes ( [figure omitted; refer to PDF] )	No ( [figure omitted; refer to PDF] )	[figure omitted; refer to PDF] value	Yes ( [figure omitted; refer to PDF] )	No ( [figure omitted; refer to PDF] )	[figure omitted; refer to PDF] value	Yes ( [figure omitted; refer to PDF] )	No ( [figure omitted; refer to PDF] )	[figure omitted; refer to PDF] value
Age (years)	62.56 ± 13.97	63.82 ± 13.02	0.37	63.86 ± 13.17	63.65 ± 13.13	0.88	65.55 ± 13.31	62.97 ± 113.00	0.01 [figure omitted; refer to PDF]
Female, [figure omitted; refer to PDF] (%)	67 (67.68)	299 (40.03)	<0.001 [figure omitted; refer to PDF]	69 (61.61)	297 (40.46)	<0.001 [figure omitted; refer to PDF]	116 (50.00)	250 (40.72)	0.02 [figure omitted; refer to PDF]
BMI (kg/m2 )	25.84 ± 4.33	25.49 ± 3.90	0.41	26.85 ± 4.39	25.33 ± 3.84	<0.001 [figure omitted; refer to PDF]	25.53 ± 3.63	25.53 ± 4.06	1.00
Waist circumference (cm)	88.96 ± 11.47	89.27 ± 10.32	0.79	93.02 ± 11.67	88.66 ± 10.14	<0.001 [figure omitted; refer to PDF]	89.17 ± 10.44	89.26 ± 10.47	0.92
Lifestyle behaviors							[...]
Smoking history, yes, [figure omitted; refer to PDF] (%)	4 (4.04)	37 (4.95)	0.69	6 (5.36)	35 (4.77)	0.79	9 (3.88)	32 (5.21)	0.42
Alcohol consumption, yes, [figure omitted; refer to PDF] (%)	0 (0)	26 (3.48)	0.06	0 (0)	26 (3.54)	0.04 [figure omitted; refer to PDF]	3 (1.29)	23 (3.75)	0.07
Exercise habits, yes, [figure omitted; refer to PDF] (%)	73 (73.74)	595 (79.65)	0.17	71 (63.39)	597 (81.34)	<0.001 [figure omitted; refer to PDF]	174 (75)	494 (80.46)	0.08
Diabetic factors
FBS (mg/dL)	149.50 ± 58.52	143.70 ± 44.70	0.35	149.10 ± 43.21	143.60 ± 47.00	0.25	145.40 ± 52.87	144.00 ± 43.93	0.71
HbAlc (%)	7.83 ± 1.68	7.66 ± 1.59	0.33	8.00 ± 1.64	7.64 ± 1.60	0.03 [figure omitted; refer to PDF]	7.77 ± 1.74	7.65 ± 1.55	0.36
DMH (year)	9.70 ± 9.19	8.82 ± 7.74	0.36	9.16 ± 8.69	8.88 ± 7.81	0.73	9.76 ± 8.82	8.60 ± 7.54	0.08
OHA use, yes, [figure omitted; refer to PDF] (%)	92 (92.93)	716 (95.85)	0.19	106 (94.64)	702 (95.64)	0.64	222 (95.69)	586 (95.44)	0.88
Insulin usage, yes, [figure omitted; refer to PDF] (%)	33 (33.33)	172 (3.03)	0.02 [figure omitted; refer to PDF]	35 (31.25)	170 (23.16)	0.06	70 (30.17)	135 (21.99)	0.01 [figure omitted; refer to PDF]
Lipid profile
TC (mg/dL)	176.90 ± 40.05	175.20 ± 36.67	0.66	180.60 ± 43.66	174.60 ± 35.91	0.17	174.30 ± 37.22	175.80 ± 37.02	0.58
TG (mg/dL)	156.60 ± 116.60	148.20 ± 163.20	0.52	157.70 ± 122.90	147.90 ± 163.20	0.45	143.00 ± 88.02	151.50 ± 177.90	0.36
HDL (mg/dL)	51.46 ± 13.20	52.46 ± 14.67	0.52	50.66 ± 13.29	52.60 ± 14.67	0.19	51.56 ± 13.25	52.64 ± 14.95	0.31
LDL (mg/dL)	109.40 ± 30.92	106.00 ± 31.30	0.31	111.90 ± 34.19	105.50 ± 30.73	0.05 [figure omitted; refer to PDF]	106.50 ± 32.82	106.30 ± 30.68	0.94
Blood pressure
SBP (mmHg)	130.60 ± 16.32	131.80 ± 14.39	0.45	132.00 ± 15.09	131.60 ± 14.56	0.79	131.30 ± 14.92	131.70 ± 14.52	0.68
DBP (mmHg)	78.34 ± 10.57	77.51 ± 9.02	0.46	77.11 ± 9.66	77.69 ± 9.14	0.53	76.99 ± 9.77	77.85 ± 8.99	0.23
Kidney function
Microalbumin (mg/dL)	26.77 ± 79.44	34.15 ± 201.8	0.50	33.01 ± 91.77	33.33 ± 202.50	0.98	29.49 ± 87.91	34.73 ± 218.3	0.62
Cr (mg/dL)	1.14 ± 0.50	1.17 ± 0.57	0.57	1.15 ± 0.48	1.17 ± 0.57	0.64	1.21 ± 0.60	1.15 ± 0.54	0.16
eGFR (mL/min)	68.29 ± 26.60	68.11 ± 21.40	0.95	67.44 ± 23.93	68.24 ± 21.77	0.72	64.40 ± 22.74	69.55 ± 21.65	<0.01 [figure omitted; refer to PDF]
ALB/Cr ( [figure omitted; refer to PDF] g/mg)	415.90 ± 1821.3	224.30 ± 851.10	0.30	309.20 ± 1140.80	237.10 ± 993.60	0.53	293.30 ± 1235.80	229.10 ± 916.70	0.47
Diabetic retinopathy, [figure omitted; refer to PDF] (%)	30 (30.30)	306 (40.96)	0.04 [figure omitted; refer to PDF]	35 (31.25)	301 (41.01)	0.05 [figure omitted; refer to PDF]	100 (43.10)	236 (38.44)	0.23

Data were presented as mean ± SD for continuous variable and as number (%) for categorical variable.

[figure omitted; refer to PDF] values were calculated using the chi-square test for categorical variable and [figure omitted; refer to PDF] -test for continuous variable. [figure omitted; refer to PDF] , [figure omitted; refer to PDF] , and [figure omitted; refer to PDF] .

BMI: body mass index; FBS: fasting blood sugar; HbA1c: glycosylated hemoglobin; DMH: duration of diabetes mellitus; OHA: oral hypoglycemic agent; TC: total cholesterol; TG: total triacylglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; GPT: glutamic pyruvic transaminase; Cr: creatinine; eGFR: estimated glomerular filtration rate; and ALB/CR: microalbumin to creatinine ratio.

Among the study participants, 363 (42.9%) showed elevated urine albumin excretion (urinary albumin/creatinine ratio ≥ 30 μ g/mg). Table 2 shows the prevalence of albuminuria according to BC types. Participants with Yang deficiency or Phlegm stasis had significantly higher prevalence of albuminuria (56.57% versus 41.10% and 56.25% versus 40.87%, resp., both [figure omitted; refer to PDF] ).

Table 2: Prevalence of albuminuria in patients with T2DM according to body constitution.

BC	Albuminuria	Nonalbuminuria	Total	[figure omitted; refer to PDF] value
( [figure omitted; refer to PDF] )	( [figure omitted; refer to PDF] )	( [figure omitted; refer to PDF] )
[figure omitted; refer to PDF] (%)	[figure omitted; refer to PDF] (%)	[figure omitted; refer to PDF] (%)
Yang deficiency
Yes	56 (56.57)	43 (43.43)	99 (100)	<0.01 [figure omitted; refer to PDF]
No	307 (41.10)	440 (58.90)	747 (100)
Phlegm stasis
Yes	63 (56.25)	49 (43.75)	112 (100)	<0.01 [figure omitted; refer to PDF]
No	300 (40.87)	434 (59.13)	734 (100)
Yin deficiency
Yes	112 (48.28)	120 (51.72)	232 (100)	0.05
No	251 (40.88)	363 (59.12)	614 (100)

BC: body constitution; DM: diabetes mellitus. [figure omitted; refer to PDF] .

[figure omitted; refer to PDF] values were calculated using the two-sided chi-square test.

Table 3 lists the unadjusted and hierarchically adjusted ORs for albuminuria associated with each BC type. Participants with Yang deficiency or Phlegm stasis were more likely to develop albuminuria (crude OR = 1.87, 95% CI = 1.22-2.85, 1.860, and 1.25-2.78, resp.). After adjustment for other risk factors, including sociodemographic characteristics, lifestyle behaviors, blood pressure, lipid profile, diabetes history, eGFR, and DR, Yang deficiency and Phlegm stasis remained strongly associated with albuminuria (OR = 2.26, 95% CI = 1.36-3.75, 1.92, and 1.19-3.08, resp.). In addition, significant joint effect of Yang deficiency and Phlegm stasis on albuminuria (OR = 3.037, 95% CI = 1.57-5.87) was observed (Table 4).

Table 3: Unadjusted and adjusted odds ratios and 95% CI for albuminuria in patients with T2DM according to body constitution.

	Albuminuria, OR (95% CI)
	Yang deficiency	Phlegm stasis	Yin deficiency
	OR (95% CI)	[figure omitted; refer to PDF] value	OR (95% CI)	[figure omitted; refer to PDF] value	OR (95% CI)	[figure omitted; refer to PDF] value
Model 1	1.87 (1.22-2.85)	0.004 [figure omitted; refer to PDF]	1.86 (1.25-2.78)	0.002 [figure omitted; refer to PDF]	1.35 (1.00-1.83)	0.053
Model 2	2.00 (1.29-3.11)	0.002 [figure omitted; refer to PDF]	1.74 (1.15-2.65)	0.010 [figure omitted; refer to PDF]	1.28 (0.93-1.74)	0.126
Model 3	1.97 (1.26-3.08)	0.003 [figure omitted; refer to PDF]	1.64 (1.07-2.50)	0.023 [figure omitted; refer to PDF]	1.25 (0.91-1.71)	0.170
Model 4	1.99 (1.26-3.14)	0.003 [figure omitted; refer to PDF]	1.66 (1.08-2.56)	0.022 [figure omitted; refer to PDF]	1.28 (0.93-1.76)	0.128
Model 5	1.93 (1.21-3.08)	0.006 [figure omitted; refer to PDF]	1.61 (1.03-2.51)	0.035 [figure omitted; refer to PDF]	1.19 (0.86-1.65)	0.298
Model 6	2.16 (1.31-3.58)	0.003 [figure omitted; refer to PDF]	1.84 (1.15-2.94)	0.011 [figure omitted; refer to PDF]	1.13 (0.80-1.60)	0.485
Model 7	2.26 (1.36-3.75)	0.002 [figure omitted; refer to PDF]	1.92 (1.19-3.08)	0.007 [figure omitted; refer to PDF]	1.13 (0.80-1.60)	0.487

Model 1 is unadjusted. Model 2 is additionally adjusted for sociodemographic characteristics. Model 3 is additionally adjusted for lifestyle behaviors. Model 4 is additionally adjusted for blood pressure and lipid profile. Model 5 is additionally adjusted for diabetic factors. Model 6 is additionally adjusted for eGFR. Model 7 is additionally adjusted for diabetic retinopathy.

Analysis by logistic regression. [figure omitted; refer to PDF] , [figure omitted; refer to PDF] .

BC: body constitution, including Yang deficiency, Ying deficiency, and Phlegm stasis. Sociodemographic characteristics: gender, age, BMI, and waist circumference. Lifestyle behaviors: smoke and alcohol drinking history and exercise. Blood pressure: SBP and DBP. Lipid profile: TG, HDL, and LDL. Diabetic factors: FBS, HbA1c, DM duration, oral hypoglycemia agent, and insulin use.

Table 4: Adjusted odds ratios and 95% CI for albuminuria in patients with T2DM according to Yang deficiency and Phlegm stasis body constitution.

	Albuminuria
OR (95% CI)	[figure omitted; refer to PDF] value
Non-Yang deficiency and non-Phlegm stasis	1.00
Yang deficiency	1.59 (0.75-3.37)	0.23
Phlegm stasis	1.30 (0.69-2.45)	0.40
Yang deficiency and Phlegm stasis	3.04 (1.57-5.87)	<0.001 [figure omitted; refer to PDF]

Non-Yang deficiency and non-Phlegm stasis as reference.

Adjusted for sociodemographic factors, lifestyle, blood pressure, lipid profile, diabetic factors, eGFR, and diabetic retinopathy.

Analysis by logistic regression. [figure omitted; refer to PDF] .

DM: diabetes mellitus. Sociodemographic factors: gender, age, BMI, and waist circumference. Lifestyle: smoking and alcohol drinking history and exercise. Blood pressure: SBP and DBP. Diabetic factors: FBS, HbA1c, DM duration, oral hypoglycemia agent, and insulin use.

4. Discussion

In our study, we considered traditional risk factors for albuminuria, including HbA1c, systolic blood pressure, DR, duration of diabetes, kidney function, and smoking [11]. After multivariate adjustment, the results of this cross-sectional study suggest that Yang deficiency and Phlegm stasis were independent risk factors for albuminuria. In addition, a significant joint effect of Yang deficiency and Phlegm stasis on albuminuria was noted. T2DM patients who had both Yang deficiency and Phlegm stasis were three times more likely to develop albuminuria.

Based on our research, this is the first clinical study to evaluate the association between albuminuria and BC in patients with T2DM. People with different BC types are more prone to certain diseases than others [17, 20, 35]. According to TCM theory, a person's BC is formed by Yin and Yang, and an imbalance between the two may cause Phlegm stasis. Yang deficiency implies that an energy level responsible for maintaining bodily functions has diminished [17], whereas Yin deficiency implies diminishing of materials (including blood, body fluid, and essence) in performing bodily functions [25]. Phlegm stasis is induced when the materials transported by the energy are impeded by external or environmental stimuli [21].

In TCM, diabetic nephropathy is referred to as an intrinsically deficient but extrinsically excessive syndrome. Deficiency of qi and excess of phlegm stasis are believed to be the main pathologic mechanism responsible for development of diabetic nephropathy [36]. Several clinical trials have aimed to discover the efficacy of TCM on diabetic proteinuria, and the results suggest that Chinese herbal medicine seems to be an effective and safe therapy option [36]. The three most commonly used herbs in different herbal preparations are Astragalus (Huang Qi), Salvia miltiorrhiza (Dan Shen), and Poria (Fuling), consecutively [36]. In TCM, the Astragalus has the effect of replenishing Qi [36, 37]. Salvia miltiorrhiza and Poria are used to activate blood circulation and to resolve phlegm [36]. By using epidemiology module, our study results, that T2DM patients with both Yang deficiency and Phlegm stasis are at a threefold risk of exhibiting albuminuria, successfully correspond with the pathology mechanism and clinical usage of certain Chinese medicine herbs.

Health promotion and disease prevention are essential in TCM. BC is modifiable and may transform as time passes or when a crucial health event occurs [38]. An epidemiological study revealed that the factors influencing BC include emotions, body weight, educational level, mental work, age, and exercise habit [39]. Chinese people have endeavored to improve their health for the past thousand years by adjusting their unbalanced BC status. A recent clinical study proved that Chinese food therapy, an effective nonpharmacological approach, can restore the Yin-Yang harmony, improve the quality of life, control blood pressure, and minimize disease symptoms in hypertensive patients with Yin deficiency [40].

From public health perspectives, screening, monitoring, and treating patients with albuminuria are strongly recommended for preventing chronic kidney disease and cardiovascular disease [41]. However, an early detection of albuminuria requires a particular but expensive immunochemical test. The questionnaire, BCQ, with favorable reliability and validity [17, 21, 25-27], has been used to distinguish patients who had different risks of certain diseases [34, 42, 43]. Furthermore, the BCQ facilitates a noninvasive, convenient, fast, and inexpensive method that can be easily applied by health care professionals to assess a patient's BC status. Our results can aid health care professionals in identifying patients with diabetes who are at a high risk of albuminuria.

With the rising burden of chronic illness and global aging population, public health research in integrative and complementary medicine has become essential [44]. People who use CAM have a greater degree of health-seeking behavior to prevent disease and promote health wellness compared with those who do not; thus, CAM providers play a critical role in health promotion and disease prevention [45]. A previous study revealed that general practitioners with more Chinese medicine knowledge referred their patients to TCM practitioners more frequently [46]. Hence, it is crucial to provide scientific evidence in support of CAM or TCM concepts that can aid in disease prevention and health promotion and to share the newly established information with health care providers. Thus, people can integrate health service effectively and safely. Therefore, we launched the Taichung Diabetic Body Constitution Study (TDBS) to evaluate the effect of BC on patients with T2DM [34, 47] and to continue following the study cohort for determining the longitudinal effect.

Our study has three major limitations. First, a potential selection bias may exist because all the study participants were recruited from a medical center. The disease severity of patients with T2DM treated at a medical center may differ from that of patients with T2DM treated in other clinical settings. The participants in our study may have had more comorbidities, poorer control of blood sugar, and a longer duration of diabetes compared with other patients. Nevertheless, the results can be applied to other T2DM patients exhibiting similar disease characteristics. Second, there was a potential confounding effect caused by other unmeasured variables because this was an observational study. We included most of the confounding factors reported in the literature to minimize the possibility of a confounding effect. Finally, we examined a cross-sectional association, which cannot make causal inference because it lacked time sequence. A cohort study is necessary to determine the casual relationship.

5. Conclusion

CAM is a public health resource for increasing the prevention of certain disease and promoting health. Distinguishing patients with T2DM who exhibit an increased risk of albuminuria is crucial for preventing diabetic nephropathy. According to TCM theory, BC is modifiable, and different BC types may affect the development and prognosis of certain diseases differently. The results of the current study suggest that T2DM patients who have both Yang deficiency and Phlegm stasis are at a threefold risk of developing albuminuria. Using BCQ to assess BC status is noninvasive, convenient, fast, and inexpensive and should be adopted in clinical practice to target patients with diabetes who are at a high risk of albuminuria.

Acknowledgments

The authors would like to thank the National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan (Contract no. MOHW104-NRICM-C-114-000-003), for financially supporting this research. All patients and study personnel in this research are commended for their participation. The authors would like to thank Hsiao-Hua Fang for her writing advice.

Conflict of Interests

The authors declare that they have no conflict of interests.

References

[1] D. R. Whiting, L. Guariguata, C. Weil, J. Shaw, "IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030," Diabetes Research and Clinical Practice , vol. 94, no. 3, pp. 311-321, 2011.

[2] Y.-Y. Huang, K.-D. Lin, Y.-D. Jiang, C.-H. Chang, C.-H. Chung, L.-M. Chuang, T.-Y. Tai, L.-T. Ho, S.-J. Shin, "Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009," Journal of the Formosan Medical Association , vol. 111, no. 11, pp. 637-644, 2012.

[3] B. M. Brenner Brenner & Rector's the Kidney , Saunders, Philadelphia, Pa, USA, 2004.

[4] A. J. Collins, R. N. Foley, B. Chavers, "US renal data system 2011 annual data report,", supplement 1 American Journal of Kidney Diseases , vol. 59, no. 1, article A7, 2012.

[5] N. Perico, I. Codreanu, A. Schieppati, G. Remuzzi, "Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?,", supplement 98 Kidney International , vol. 68, pp. S21-S24, 2005.

[6] P. Clarke, A. Gray, R. Legood, A. Briggs, R. Holman, "The impact of diabetes-related complications on healthcare costs: results from the united kingdom prospective diabetes study (ukpds study no. 65)," Diabetic Medicine , vol. 20, no. 6, pp. 442-450, 2003.

[7] A. J. Collins, B. Kasiske, C. Herzog, B. Chavers, R. Foley, D. Gilbertson, R. Grimm, J. Liu, T. Louis, W. Manning, A. Matas, M. McBean, A. Murray, W. St. Peter, J. Xue, Q. Fan, H. Guo, S. Li, S. Li, T. Roberts, J. Snyder, C. Solid, C. Wang, E. Weinhandl, C. Arko, S.-C. Chen, F. Dalleska, F. Daniels, S. Dunning, J. Ebben, E. Frazier, R. Johnson, D. Sheets, B. Forrest, D. Berrini, E. Constantini, S. Everson, P. Frederick, P. Eggers, L. Agodoa, "Excerpts from the united states renal data system 2004 annual data report: atlas of end-stage renal disease in the united states-perface," American Journal of Kidney Diseases , vol. 45, no. 1, pp. A5-A7, 2005.

[8] W.-C. Yang, S.-J. Hwang, Taiwan Society of Nephrology, "Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance," Nephrology Dialysis Transplantation , vol. 23, no. 12, pp. 3977-3982, 2008.

[9] H. H. Parving, B. Oxenbøll, P. A. Svendsen, J. S. Christiansen, A. R. Andersen, "Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion," Acta Endocrinologica , vol. 100, no. 4, pp. 550-555, 1982.

[10] R. Retnakaran, C. A. Cull, K. I. Thorne, A. I. Adler, R. R. Holman, "Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74," Diabetes , vol. 55, no. 6, pp. 1832-1839, 2006.

[11] H.-H. Parving, J. B. Lewis, M. Ravid, G. Remuzzi, L. G. Hunsicker, "Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective," Kidney International , vol. 69, no. 11, pp. 2057-2063, 2006.

[12] Z. S. Chi, E. T. Lee, M. Lu, P. H. Bennett, H. Keen, "Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes," Diabetologia , vol. 44, no. 2, pp. S82-S86, 2001.

[13] E. H. Gladstone, "Diabetes in chronic kidney disease and end-stage renal disease: highlights from the USRDS 2005 annual data report," Diabetes , vol. 55, pp. A179, 2006.

[14] S. K. Pal, "Complementary and alternative medicine: an overview," Current Science , vol. 82, no. 5, pp. 518-524, 2002.

[15] P. M. Barnes, E. Powell-Griner, K. McFann, "Complementary and alternative medicine use among adults: United states, 2002," Seminars in Integrative Medicine , pp. 54-71, Elsevier, 2004.

[16] F. Cheung, "TCM made in China," Nature , vol. 480, no. 7378, pp. S82-S83, 2011.

[17] Y.-C. Su, L.-L. Chen, J.-D. Lin, J.-S. Lin, Y.-C. Huang, J.-S. Lai, "BCQ+: a body constitution questionnaire to assess Yang-Xu. Part I: establishment of a first final version through a Delphi process," Forschende Komplementarmedizin , vol. 15, no. 6, pp. 327-334, 2008.

[18] Q. Wang, "Individualized medicine, health medicine, and constitutional theory in Chinese medicine," Frontiers of Medicine , vol. 6, no. 1, pp. 1-7, 2012.

[19] W. Wong, C. L. K. Lam, V. T. Wong, Z. M. Yang, E. T. C. Ziea, A. K. L. Kwan, "Validation of the constitution in Chinese medicine questionnaire: does the traditional Chinese medicine concept of body constitution exist?," Evidence-Based Complementary and Alternative Medicine , vol. 2013, 2013.

[20] J. Wang, Q. Wang, L. Li, Y. Li, H. Zhang, L. Zheng, L. Yang, Y. Zheng, Y. Yang, G. Peng, Y. Zhang, Y. Han, "Phlegm-dampness constitution: genomics, susceptibility, adjustment and treatment with traditional Chinese medicine," The American Journal of Chinese Medicine , vol. 41, no. 2, pp. 253-262, 2013.

[21] J.-D. Lin, J.-S. Lin, L.-L. Chen, C.-H. Chang, Y.-C. Huang, Y.-C. Su, "BCQs: a body constitution questionnaire to assess stasis in traditional Chinese medicine," European Journal of Integrative Medicine , vol. 4, no. 4, pp. e379-e391, 2012.

[22] W. Qi, "Status and prospect of constitutional theory in traditional Chinese medicine," China Journal of Basic Medicine in Traditional Chinese Medicine , vol. 8, no. 2, pp. 6-17, 2002.

[23] S. Tan, K. Tillisch, R. Bolus, T. I. Olivas, B. M. R. Spiegel, B. Naliboff, L. Chang, E. A. Mayer, "Traditional Chinese medicine based subgrouping of irritable bowel syndrome patients," The American Journal of Chinese Medicine , vol. 33, no. 3, pp. 365-379, 2005.

[24] J.-L. Tang, B.-Y. Liu, K.-W. Ma, "Traditional Chinese medicine," The Lancet , vol. 372, no. 9654, pp. 1938-1940, 2008.

[25] J.-D. Lin, L.-L. Chen, J.-S. Lin, C.-H. Chang, Y.-C. Huang, Y.-C. Su, "BCQ-: a body constitution questionnaire to assess Yin-Xu. Part I: establishment of a provisional version through a delphi process," Forschende Komplementarmedizin , vol. 19, no. 5, pp. 234-241, 2012.

[26] L.-L. Chen, J.-S. Lin, J.-D. Lin, C.-H. Chang, H.-W. Kuo, W.-M. Liang, Y.-C. Su, "BCQ+: a body constitution questionnaire to assess Yang-Xu. Part II: evaluation of reliability and validity," Forschende Komplementarmedizin , vol. 16, no. 1, pp. 20-27, 2009.

[27] J. S. Lin, L. L. Chen, J. D. Lin, "BCQ-: a body constitution questionnaire to assess yin-xu. Part II: evaluation of reliability and validity," Forschende Komplementarmedizin , vol. 19, no. 6, pp. 285-292, 2012.

[28] E. M. Kearney, J. N. Mount, G. F. Watts, B. M. Slavin, P. R. Kind, "Simple immunoturbidimetric method for determining urinary albumin at low concentrations using cobas-bio centrifugal analyser," Journal of Clinical Pathology , vol. 40, no. 4, pp. 465, 1987.

[29] American Diabetes Association, "Standards of medical care in diabetes-2011,", supplement 1 Diabetes Care , vol. 34, pp. S11-S61, 2011.

[30] G. Eknoyan, T. Hostetter, G. L. Bakris, L. Hebert, A. S. Levey, H.-H. Parving, M. W. Steffes, R. Toto, K. Willis, "Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)," American Journal of Kidney Diseases , vol. 42, no. 4, pp. 617-622, 2003.

[31] A. S. Levey, J. Coresh, E. Balk, "National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification," Annals of Internal Medicine , vol. 139, no. 2, pp. 137-147, 2003.

[32] C. P. Wilkinson, F. L. Ferris III, R. E. Klein, P. P. Lee, C. D. Agardh, M. Davis, D. Dills, A. Kampik, R. Pararajasegaram, J. T. Verdaguer, F. Lum, "Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales," Ophthalmology , vol. 110, no. 9, pp. 1677-1682, 2003.

[33] A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, D. Roth, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation," Annals of Internal Medicine , vol. 130, no. 6, pp. 461-470, 1999.

[34] C.-H. Lee, T.-C. Li, C.-I. Tsai, "Yang deficiency body constitution acts as a predictor of diabetic retinopathy in patients with type 2 diabetes: Taichung diabetic body constitution study," Evidence-Based Complementary and Alternative Medicine , vol. 2015, 2015.

[35] H. M. Langevin, G. J. Badger, B. K. Povolny, R. T. Davis, A. C. Johnston, K. J. Sherman, J. R. Kahn, T. J. Kaptchuk, "Yin scores and yang scores: a new method for quantitative diagnostic evaluation in traditional Chinese medicine research," Journal of Alternative and Complementary Medicine , vol. 10, no. 2, pp. 389-395, 2004.

[36] Y. Xiao, Y. Liu, K. Yu, L. Zhou, J. Bi, J. Cheng, F. Li, R. Luo, X. Zhao, "The effect of Chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: a systematic review and meta-analysis," Evidence-Based Complementary and Alternative Medicine , vol. 2013, 2013.

[37] X. Tu, F. Liu, J. B. Jordan, X. F. Ye, P. Fu, F. Wang, S. Zhong, "'Huang Qi Elixir' for proteinuria in patients with diabetic nephropathy: a study protocol for a randomized controlled pilot trial," Trials , vol. 14, article 223, 2013.

[38] S.-H. Kuo, H.-L. Wang, T.-C. Lee, "Traditional Chinese medicine perspective on constitution transformations in perinatal women: a prospective longitudinal study," Women and Birth , vol. 28, no. 2, pp. 106-111, 2015.

[39] Y. Z. Sun, P. Liu, Y. Zhao, L. Jia, Y. He, S. A. Xue, X. Zheng, Z. Wang, N. Wang, J. Chen, "Characteristics of TCM constitutions of adult Chinese women in Hong Kong and identification of related influencing factors: a cross-sectional survey," Journal of Translational Medicine , vol. 12, no. 1, article 140, 2014.

[40] C. Z. Shen, S. M.-C. Pang, E. W.-Y. Kwong, Z. Cheng, "The effect of Chinese food therapy on community dwelling Chinese hypertensive patients with Yin-deficiency," Journal of Clinical Nursing , vol. 19, no. 7-8, pp. 1008-1020, 2010.

[41] P. E. de Jong, G. C. Curhan, "Screening, monitoring, and treatment of albuminuria: public health perspectives," Journal of the American Society of Nephrology , vol. 17, no. 8, pp. 2120-2126, 2006.

[42] K.-C. Huang, C.-C. Chen, Y.-C. Su, J.-S. Lin, C.-T. Chang, T.-Y. Wang, R.-H. Chen, F.-J. Tsai, "The relationship between stasis-stagnation constitution and peripheral arterial disease in patients with type 2 diabetes," Evidence-Based Complementary and Alternative Medicine , vol. 2014, 2014.

[43] H.-L. Wang, T.-C. Lee, S.-H. Kuo, F.-H. Chou, L.-L. Chen, Y.-C. Su, L.-M. Chen, "Relationships among constitution, stress, and discomfort in the first trimester," Evidence-Based Complementary and Alternative Medicine , vol. 2012, 2012.

[44] J. Adams, E. Sommers, N. Robinson, "Public health and health services research in integrative medicine: an emerging, essential focus," European Journal of Integrative Medicine , vol. 5, no. 1, pp. 1-3, 2013.

[45] C. Hawk, H. Ndetan, M. W. Evans, "Potential role of complementary and alternative health care providers in chronic disease prevention and health promotion: an analysis of national health interview survey data," Preventive Medicine , vol. 54, no. 1, pp. 18-22, 2012.

[46] J. L. Wardle, D. W. Sibbritt, J. Adams, "Referral to Chinese medicine practitioners in Australian primary care: a survey of New South Wales rural and regional general practitioners," Chinese Medicine , vol. 8, article 8, 2013.

[47] C.-I. Tsai, Y.-C. Su, S.-Y. Lin, I.-T. Lee, C.-H. Lee, T.-C. Li, "Reduced health-related quality of life in body constitutions of Yin-Xu, and Yang-Xu, stasis in patients with type 2 diabetes: taichung diabetic body constitution study," Evidence-Based Complementary and Alternative Medicine , vol. 2014, 2014.